Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT) | MicrobiomeTrials
Description of Characteristics, Such as Age, Previous and Concurrent Treatments, Associated Diseases, of Patients With Asthma Treated With Dupilumab (DUPIXENT)
CompletedOBSERVATIONAL
Trial Details
Start: 2020-11-02Est. Completion: 2026-06-18
Enrollment target: 376 participants
Locations
Investigational Site Number : 0320005, La Plata, Buenos Aires, Argentina
Investigational Site Number : 0320006, Villa Rosa, Buenos Aires, Argentina
Investigational Site Number : 0320001, Ciudad Autonoma Bs As, Argentina
Investigational Site Number : 0320008, Ciudad Autonoma Buenos Aires, Argentina
Investigational Site Number : 0320009, San Miguel de Tucumán, Argentina
Investigational Site Number : 0320004, Santa Fe, Argentina
Investigational Site Number : 1520001, Santiago, Reg Metropolitana de Santiago, Chile
Investigational Site Number : 1520002, Quillota, Valparaiso, Chile
Investigational Site Number : 1700009, Barranquilla, Colombia
Investigational Site Number : 1700004, Bogotá, Colombia
Investigational Site Number : 1700003, Bucaramanga, Colombia
Investigational Site Number : 3760008, Ashdod, Israel
Investigational Site Number : 3760004, Ashkelon, Israel
Investigational Site Number : 3760005, Jerusalem, Israel
Investigational Site Number : 3760003, Jerusalem, Israel
Investigational Site Number : 3760001, Kfar Saba, Israel
Other microbiome trials you might be interested in